MRSA Eradication and Decolonization in Children
NCT02127658 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2024-06-25
Summary
In this study, the investigators intend to compare therapies (abscess surgery and hygiene education compared to abscess surgery and hygiene education followed by decolonization) for Methicillin-Resistant Staphylococcus Aureus skin and soft tissue infections (MRSA SSTI) to determine which is the more effective treatment. The investigators focus on patient centered outcomes as described by the families of MRSA infected patients. Such outcomes are likely to include quality of life, side effects, and school and work attendance. The hypothesis is that treatment with decolonization will decrease the rate of SSTI recurrence and improve overall patient centered outcomes. The rationale is that negative outcomes such as recurrence may be avoided through the use of readily available prevention strategies, but that it is important to determine how burdensome those prevention strategies are for patients and families.
Conditions
- MRSA
Interventions
- OTHER
-
Hygiene education
Participants will receive specific hygiene instructions according to existing recommendations.
- OTHER
-
Sodium Hypochlorite
Participants in this intervention group will receive the same hygiene instructions as the participants in the first intervention group. In addition, intervention number 2 will include the following for all consented household members: Twice weekly 15 minute soaks in diluted bleach water (2/3 cup of 8.25% sodium hypochlorite \[Clorox; The Clorox Company\] for a standard 50 gallon tub of water, or a teaspoon for each 1.5 gallons of water used) for the duration of 6 weeks. Application of 2% mupirocin ointment by the use of clean swab to the bilateral anterior nares twice daily for ten days
- DRUG
-
Mupirocin ointment
Participants in this intervention group will receive the same hygiene instructions as the participants in the first intervention group. In addition, intervention number 2 will include the following for all consented household members: Twice weekly 15 minute soaks in diluted bleach water (2/3 cup of 8.25% sodium hypochlorite \[Clorox; The Clorox Company\] for a standard 50 gallon tub of water, or a teaspoon for each 1.5 gallons of water used) for the duration of 6 weeks. Application of 2% mupirocin ointment by the use of clean swab to the bilateral anterior nares twice daily for ten days
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Paul I Musey, MD · Indiana University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-18
- Primary Completion
- 2020-07-01
- Completion
- 2020-07-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
NCT01349192 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization
NCT01438515 ·Status: COMPLETED ·Phase: NA
-
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
NCT02690415 ·Status: COMPLETED
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT00966446 ·Status: COMPLETED ·Phase: NA
-
Whole Body Washing With Chlorhexidine for the Eradication of MRSA
NCT00266448 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Mupirocin Decolonization on the Nasal Microbiome
NCT02045329 ·Status: TERMINATED
-
Stop Community MRSA Colonization Among Patients
NCT02029872 ·Status: COMPLETED ·Phase: PHASE4
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 ·Status: COMPLETED ·Phase: NA
-
MRSA in a Trauma Population: Does Decolonization Prevent Infection?
NCT01820455 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
NCT01141101 ·Status: COMPLETED
-
Staph Household Intervention for Eradication (SHINE)
NCT02572791 ·Status: COMPLETED ·Phase: PHASE4
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
Retapamulin as a Decolonizing Agent for MRSA
NCT03304873 ·Status: COMPLETED ·Phase: PHASE3
-
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
NCT02223520 ·Status: COMPLETED ·Phase: NA
-
NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized Children
NCT06872099 ·Status: RECRUITING
-
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
NCT01302210 ·Status: COMPLETED
-
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
NCT00822276 ·Status: COMPLETED
-
Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients
NCT05696132 ·Status: TERMINATED ·Phase: PHASE2
-
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
NCT01594827 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Staphylococcal (Staph) Infection
NCT00108160 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)
NCT00790608 ·Status: TERMINATED ·Phase: PHASE2
-
Hospital Acquired and Community Acquired MRSA in GI Lab
NCT00577343 ·Status: WITHDRAWN